Stockreport

Trevi Therapeutics Announces Appointment of James V. Cassella, Ph.D., as Chief Development Officer [Yahoo! Finance]

Trevi Therapeutics, Inc.  (TRVI) 
PDF clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in idiopathic pulmonary [Read more]